Open Access Helper

OpenAlex Citation Counts

OpenAlex Citations Logo

OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!

If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.

Requested Article:

Hepatocellular carcinoma risk in patients with chronic hepatitis B receiving tenofovir- vs. entecavir-based regimens: Individual patient data meta-analysis
Won‐Mook Choi, Terry Cheuk‐Fung Yip, Grace Lai‐Hung Wong, et al.
Journal of Hepatology (2022) Vol. 78, Iss. 3, pp. 534-542
Open Access | Times Cited: 45

Showing 1-25 of 45 citing articles:

Personalised management of patients with hepatocellular carcinoma: a multiparametric therapeutic hierarchy concept
Alessandro Vitale, Giuseppe Cabibbo, Massimo Iavarone, et al.
The Lancet Oncology (2023) Vol. 24, Iss. 7, pp. e312-e322
Closed Access | Times Cited: 113
EASL Clinical Practice Guidelines on the management of hepatocellular carcinoma
Bruno Sangro, Lorenza Rimassa, Maxime Ronot, et al.
Journal of Hepatology (2024)
Closed Access | Times Cited: 30
Merits and boundaries of the BCLC staging and treatment algorithm: Learning from the past to improve the future with a novel proposal
Franco Trevisani, Alessandro Vitale, Masatoshi Kudo, et al.
Journal of Hepatology (2024) Vol. 80, Iss. 4, pp. 661-669
Closed Access | Times Cited: 25
Development of a sandwich-type electrochemical DNA sensor based on CeO2/AuPt nanoprobes for highly sensitive detection of hepatitis B virus DNA
Jian Mao, Jiaxin Wang, Hongli Chen, et al.
Bioelectrochemistry (2025) Vol. 163, pp. 108901-108901
Closed Access | Times Cited: 1
Hepatocellular carcinoma: Revising the surgical approach in light of the concept of multiparametric therapeutic hierarchy
Umberto Cillo, Enrico Gringeri, F. D’Amico, et al.
Digestive and Liver Disease (2025)
Closed Access | Times Cited: 1
Therapeutic effects of reduced glutathione on liver function, fibrosis, and HBV DNA clearance in chronic hepatitis B patients
Qiyao Wei, Jing Zhao
BMC Gastroenterology (2025) Vol. 25, Iss. 1
Open Access | Times Cited: 1
Role of hepatotropic viruses in promoting hepatocellular carcinoma—current knowledge and recent advances
Piotr Starnawski, Klaudia Nowak, Zuzanna Augustyn, et al.
Medical Oncology (2025) Vol. 42, Iss. 4
Closed Access | Times Cited: 1
Hepatitis B virus as a risk factor for hepatocellular carcinoma: There is still much work to do
Walaa Abdelhamed, Mohamed El‐Kassas
Liver Research (2024) Vol. 8, Iss. 2, pp. 83-90
Open Access | Times Cited: 7
The Role of Hepatitis Viruses as Drivers of Hepatocancerogenesis
Mario Capasso, Valentina Cossiga, Maria Guarino, et al.
Cancers (2024) Vol. 16, Iss. 8, pp. 1505-1505
Open Access | Times Cited: 6
Past, present, and future of long-term treatment for hepatitis B virus
Teresa Broquetas, J.A. Carrión
World Journal of Gastroenterology (2023) Vol. 29, Iss. 25, pp. 3964-3983
Open Access | Times Cited: 13
Entecavir versus tenofovir for prevention of hepatitis B virus-associated hepatocellular carcinoma after curative resection: study protocol for a randomized, open-label trial
Li-Xin Pan, Yiyang Wang, Zhonghai Li, et al.
Trials (2024) Vol. 25, Iss. 1
Open Access | Times Cited: 4
Effect of potent nucleos(t)ide analog on alpha fetoprotein changes and occurrence of hepatocellular carcinoma in patients with chronic hepatitis B
Qianqian Ma, Junzhao Ye, Ling Luo, et al.
Infectious Agents and Cancer (2025) Vol. 20, Iss. 1
Open Access
Hepatitis B-Induced Hepatocellular Carcinoma: Understanding Viral Carcinogenesis and Disease Management
Yasamin Farbod, Husain Kankouni, Maryam Moini, et al.
Journal of Clinical Medicine (2025) Vol. 14, Iss. 7, pp. 2505-2505
Open Access
Tenofovir alafenamide versus entecavir in treating patients with chronic hepatitis B: A meta-analysis
Jian-Xing Luo, Guo Chen, Xiao Hu, et al.
Gastroenterología y Hepatología (English Edition) (2025) Vol. 48, Iss. 4, pp. 502276-502276
Closed Access
EASL Clinical Practice Guidelines on the management of hepatitis B virus infection
Markus Cornberg, Lisa Sandmann, Jerzy Jaroszewicz, et al.
Journal of Hepatology (2025)
Closed Access
Biomarkers predicting the efficacy of immune checkpoint inhibitors in hepatocellular carcinoma
Ran Qin, Tianqiang Jin, Feng Xu
Frontiers in Immunology (2023) Vol. 14
Open Access | Times Cited: 8
Nucleos(t)ide analogs for hepatitis B virus infection differentially regulate the growth factor signaling in hepatocytes
Ryogo Shimizu, Kazuhisa Murai, Kensuke Tanaka, et al.
Hepatology Communications (2024) Vol. 8, Iss. 1
Open Access | Times Cited: 2
Mortality in patients with chronic hepatitis B treated with tenofovir or entecavir: A multinational study
Tyng‐Yuan Jang, Po‐Cheng Liang, Dae Won Jun, et al.
Journal of Gastroenterology and Hepatology (2024) Vol. 39, Iss. 6, pp. 1190-1197
Closed Access | Times Cited: 2
Current trends and advances in antiviral therapy for chronic hepatitis B
Juan Li, Siyi Liu, Qijuan Zang, et al.
Chinese Medical Journal (2024)
Open Access | Times Cited: 2
Recent advancements in polyaniline-based biosensors for diagnosis of cancers: a comprehensive review
Mojtaba Hosseine, Ali Bakhshi, Seyed Morteza Naghib, et al.
TrAC Trends in Analytical Chemistry (2024) Vol. 181, pp. 118040-118040
Closed Access | Times Cited: 2
Lower Incidence of Hepatocellular Carcinoma with Tenofovir Alafenamide in Chronic Hepatitis B: Evidence from a Large-Scale Cohort
Hyejin Yoo, Jin Young Kim, Jeong‐Ju Yoo, et al.
JHEP Reports (2024) Vol. 7, Iss. 2, pp. 101268-101268
Open Access | Times Cited: 2
A Territory-wide Study Investigating the Dose and Efficacy of Different Bacillus Calmette-Guérin Strains in Patients with Intermediate- and High-risk Non–muscle-invasive Bladder Cancer
Kang Liu, Hongda Zhao, Xuan Chen, et al.
European Urology Oncology (2023) Vol. 7, Iss. 3, pp. 438-446
Closed Access | Times Cited: 4
Prevention in Hepatology
Ana María Muñoz-Restrepo, María Cristina Navas, Jimmy Daza, et al.
Journal of Personalized Medicine (2024) Vol. 14, Iss. 2, pp. 132-132
Open Access | Times Cited: 1
RBM12 drives PD-L1-mediated immune evasion in hepatocellular carcinoma by increasing JAK1 mRNA translation
Hexu Han, Qian Shi, Yue Zhang, et al.
Oncogene (2024) Vol. 43, Iss. 41, pp. 3062-3077
Closed Access | Times Cited: 1
Predictors of Functional Cure of Chronic Hepatitis B Virus Infection: A Long-Term Follow-Up Study
Jia‐Feng Wu, Chi‐San Tai, Kai‐Chi Chang, et al.
Clinical Gastroenterology and Hepatology (2024)
Closed Access | Times Cited: 1
Page 1 - Next Page

Scroll to top